"cancer related mortalities" trang 10 - tải miễn phí từ tailieuXANH
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2 - positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)

Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2 - positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
10    70    0
MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India

MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India
6    51    0
New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer

New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer
9    51    0
International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: The EORTC-QLQTC-26

International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: The EORTC-QLQTC-26
11    54    0
Immune-related genes in tumor-specific CD4+ and CD8+ T cells in colon cancer

Immune-related genes in tumor-specific CD4+ and CD8+ T cells in colon cancer
11    52    0
Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: A qualitative study

Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: A qualitative study
11    65    0
MicroRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer

MicroRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer
8    52    0
Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance

Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance
10    99    0
Design of a randomized controlled trial of physical training and cancer (Phys-Can) – the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome

Design of a randomized controlled trial of physical training and cancer (Phys-Can) – the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome
12    60    0
Methylation of WT1, CA10 in peripheral blood leukocyte is associated with breast cancer risk: A case-control study

Methylation of WT1, CA10 in peripheral blood leukocyte is associated with breast cancer risk: A case-control study
9    53    0
Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study
8    54    0
Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines

Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines
11    49    0
RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: Results from a Europewide survey of pathology centres

RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: Results from a Europewide survey of pathology centres
11    53    0
Activins and their related proteins in colon carcinogenesis: Insights from early and advanced azoxymethane rat models of colon cancer

Activins and their related proteins in colon carcinogenesis: Insights from early and advanced azoxymethane rat models of colon cancer
16    45    0
Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients

Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients
9    46    0
The Alberta Moving Beyond Breast Cancer (AMBER) cohort study: Recruitment, baseline assessment, and description of the first 500 participants

The Alberta Moving Beyond Breast Cancer (AMBER) cohort study: Recruitment, baseline assessment, and description of the first 500 participants
9    54    0
Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes

Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes
17    56    0
Stroke related to androgen deprivation therapy for prostate cancer: A meta-analysis and systematic review

Stroke related to androgen deprivation therapy for prostate cancer: A meta-analysis and systematic review
7    63    0
Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy

Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy
10    65    0
Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling

Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling
11    43    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.